🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background : Glaucoma is a common disease, potentially blinding, characteri...
Status
Completed
Location
CHU Amiens
Start Date
2015-03-05
Trial ID
NCT02178085
Treatments Being Tested
This phase II trial compares the effect of GI-102 alone and in combination ...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-04-01
Trial ID
NCT07301268
This phase II trial studies how well giving zanidatamab before surgery (neo...
Status
Recruiting
Location
Emory University Hospital Midtown
Start Date
2026-04-07
Trial ID
NCT07405476
The investigators hypothesize that 4Dimensional Phase Contrast Magnetic Res...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2014-08-05
Trial ID
NCT02618447
Treatments Being Tested
This phase II trial studies how well olaparib and cediranib maleate work in...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2016-05-23
Trial ID
NCT02345265
To examine the ability of MRA to measure the effect of GTN on the intra-cra...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00256802
Treatments Being Tested
This study aims at investigating the diagnostic accuracy of magnetic resona...
Status
Terminated
Location
University Medical Center Mannheim
Start Date
2008-05
Trial ID
NCT00717639
Treatments Being Tested
The primary objective of this study is to determine if quantitative Dynamic...
Status
Completed
Location
The Hospital for Sick Children
Start Date
2010-09
Trial ID
NCT01192360
This phase II ComboMATCH treatment trial compares the usual treatment alone...
Status
Terminated
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-09-13
Trial ID
NCT05554354
This phase I trial tests the safety, side effects, and best dose of azenose...
Status
Recruiting
Location
UT MD Anderson Cancer Center
Start Date
2025-02-03
Trial ID
NCT06364410